Overactive Bladder (OAB) Therapeutics Market

Overactive Bladder (OAB) Therapeutics Market: Global Industry Analysis and Forecast 2015 - 2021

Overactive Bladder (OAB) Therapeutics Market Segmented By generic drugs such as flavoxate, oxybutynin, tolterodine also have Anticholinergic agents considered as the first line treatment.

Market Overview

Overactive bladder is a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency or nocturia. The common symptoms of OAB includes urgency, high urinary frequency and urge incontinence. Anticholinergic agents are considered as the first line treatment for overactive bladder disorders. Flavoxate, oxybutynin, tolterodine are some of the generic drugs used for the treatment of overactive bladder. These drugs acts by antagonizing cholinergic receptors that provides the relief from the frequent urination.

Increasing population diagnosed with overactive bladder disorder coupled with aging population will drive the growth of this market. Furthermore, manufacturers are continuously increasing their research and development expenditure to develop novel drugs such as neuromuscular blocking agents with innovative mechanism of actions.

This factor will provide healthy platform to develop this market and hence drives the market growth. In addition, efforts of many key players launching consumer campaigns aiming to increase the awareness of this disorder among the people will further boost the growth of this market.

However, patent expiry of the key drugs namely Oxytrol, Toviaz and Detrol may significantly restrain the growth of this market. Unfavorable side effect such as bladder muscle contraction, mental confusion, dry mouth and constipation coupled with low efficacy of available drugs will also restrain the growth of this market.

Geographically, North America is considered to be the largest market of overactive bladder therapeutics owing to introduction of advanced techniques for the treatment of these disorder. Europe is considered as second largest market of overactive bladder therapeutics.

The growth is mainly attributed to widespread availability of generic drugs for the treatment of this disorder. In addition, Asia-Pacific region is the emerging markets for overactive bladder therapeutics market because of rising healthcare awareness among the people.

Various key players contributing to the global overactive bladder therapeutics market includes Allergan, Inc. , Antares Pharma, Inc , Astellas Pharma, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Limited  and others.

Find Out More about the Report Coverage

Key geographies evaluated in this report are:

  • North America
    • U.S
    • Canada
  • Europe
    • France, Germany, Italy, Spain, and the UK
    • Eastern Europe
    • CIS
  • APAC
    • China
    • India
    • Japan
    • Australia
    • Others
  • Latin America
    • Argentina
    • Brazil
    • Others

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Key feaures of this report

  • Drivers, restraints, and challenges shaping the Overactive Bladder (OAB) Therapeutics market dynamics
  • Latest innovations and key events in the industry
  • Analysis of business strategies of the top players
  • Overactive Bladder (OAB) Therapeutics market estimates and forecasts(2015 -2021)

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Recommendations

Home Infusion Therapy Market

Global Home Infusion Therapy Devices Market was valued at US$ 15,905.1 Million. The market is estimated to surpass to US$ 26,747 Million by 2020, expanding at 55% CAGR.

Dental Implants Market

The global dental implants market is valued at nearly at US$ 4.2 Bn in 2021, and is expected to expand 2 X by 2031. The U.S. market for dental implants is valued at around US$ 850 Mn in 2021, with more 3.5 Mn implants carried out each year..

Sickle Cell Disease Treatment Market

Global Sickle Cell Disease Treatment Market - explore share, size, revenue, valuation, CAGR, regional outlook, key players, competitive landscape, trends & forecast.

Compression Socks Market

The global compression socks market is expected to expand at a considerable growth over the next ten years at a CAGR of around 5%, and observe an increase in the value from US$ 630 Mn in 2021 to over US$ 1 Bn by the end of 2031..

Our Clients

Our Clients